How can hemolysis be confirmed in a patient with end-stage renal disease undergoing hemodialysis, particularly using blood conductivity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Conductivity Monitoring for Hemolysis During Hemodialysis

Blood conductivity measurement can detect hemolysis during hemodialysis by identifying increases in electrical conductivity that occur when red blood cells rupture and release intracellular contents, though this is an emerging monitoring technique rather than a standard diagnostic approach recommended in current guidelines.

Understanding the Mechanism

  • As red blood cells rupture during hemolysis, intracellular ions are released into the plasma, increasing the overall electrical conductivity of blood 1
  • Small changes in hemolysis levels can be detected through simple resistance measurements in real-time, providing continuous monitoring capability 1
  • This represents a potential early warning system for detecting blood damage before clinical manifestations become severe 1

Clinical Recognition of Hemolysis During Hemodialysis

Immediate Clinical Signs

  • Visual changes in blood color within the dialysis circuit are the most immediate indicator—blood becomes darker or takes on a characteristic "cherry red" appearance 2
  • Acute onset of respiratory distress with hypoxemia typically occurs within 2 hours of dialysis initiation when hemolysis is significant 2
  • Associated symptoms include abdominal pain, nausea, vomiting, and chest pain with arterial hypertension 2

Equipment-Related Causes

  • Kinked arterial tubing is a common mechanical cause that can lead to excessive negative pressure and red blood cell rupture 2
  • Abnormal pre-pump arterial pressures (particularly values <-200 mmHg) should trigger immediate investigation for hemolysis 3
  • Post-pump pressures should be monitored alongside pre-pump readings, though machine alarms may not always activate during early hemolysis 2

Diagnostic Confirmation

Laboratory Assessment

  • Immediate blood workup should be obtained when hemolysis is suspected, including hemoglobin, haptoglobin, lactate dehydrogenase (LDH), and plasma-free hemoglobin 2
  • Blood samples should be drawn directly from the circuit when color changes are observed, before terminating dialysis 2

Conductivity Monitoring Advantages

  • Real-time conductivity monitoring offers continuous surveillance rather than intermittent sampling 1
  • This technique can detect hemolysis earlier than visual inspection or clinical symptoms alone 1
  • The method is simple and non-invasive, requiring only resistance measurement equipment 1

Immediate Management Protocol

Emergency Response Steps

  1. Stop hemodialysis immediately without blood restitution when hemolysis is suspected based on visual changes or clinical deterioration 2
  2. Perform tubing checkup to identify mechanical causes such as kinking, excessive negative pressure, or equipment malfunction 2
  3. Administer oxygen therapy for respiratory support 2
  4. Give IV methylprednisolone (40 mg) to reduce inflammatory response 2
  5. Administer IV furosemide (100 mg) to promote diuresis and prevent acute kidney injury from hemoglobin precipitation 2

Critical Care Considerations

  • Urgent blood transfusion should be ordered immediately for significant hemolysis with hemodynamic compromise 2
  • Transfer to intensive care unit is warranted for severe cases requiring artificial ventilation 2
  • Extracorporeal cytokine adsorption (CytoSorb®) may be considered for 24 hours in severe cases to remove inflammatory mediators 2
  • Regular hemodialysis can typically resume after stabilization, usually within days of the acute event 2

Prevention and Monitoring

Equipment Maintenance

  • Regular blood pump calibration should be verified, as inaccurate calibration can contribute to hemolysis risk 3
  • Dialysis machine maintenance logs must document calibration dates and results 3
  • Extracorporeal pressures should be compared to previous sessions at the prescribed blood flow rate 3

Anticoagulation Considerations

  • Review anticoagulation protocols if dialyzer clotting is noted, as this can increase hemolysis risk 3
  • Hemostatic changes in hemodialysis patients may predispose to both thrombotic and bleeding complications 4

Important Clinical Pitfalls

  • Do not assume machine alarms will always activate during early hemolysis—visual inspection and clinical vigilance remain essential 2
  • Avoid reinfusing blood to the patient once hemolysis is suspected, as this introduces additional free hemoglobin and cellular debris 2
  • Do not delay emergency response while waiting for laboratory confirmation—clinical suspicion based on visual changes and symptoms should trigger immediate action 2
  • Blood conductivity monitoring is a research tool and not yet a standard of care; clinical judgment and traditional monitoring remain primary 1

References

Research

Hemolysis in a Patient during Hemodialysis.

Case reports in nephrology and dialysis, 2021

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hemostatic changes in patients with end stage renal disease undergoing hemodialysis.

Clinica chimica acta; international journal of clinical chemistry, 2010

Related Questions

How to identify hemolysis in a patient with end-stage renal disease undergoing hemodialysis?
Is hydration still recommended in SCD with hypervolemia due to decreased GFR?
What is the management protocol for a code blue during hemodialysis in a patient with impaired renal function?
What is the management plan for a patient with sickle cell disease, history of chronic kidney disease (CKD) stage 2 and pulmonary embolism (PE), with acute impaired renal function?
What is the target hemoglobin range in a patient with Sickle Cell Disease (SCD)?
What is the appropriate management for a patient presenting with fever and headache who has tested positive for typhidot IgG, indicating potential current or past typhoid fever infection?
Can a single-view chest X-ray (CXR) be used to confirm chest tube patency in patients with recent trauma, surgery, or significant respiratory conditions?
What is the role of priming autologous immune cells, such as T cells or dendritic cells, in cancer immunotherapy for a patient with a confirmed diagnosis of cancer?
What is the best approach to manage hypertriglyceridemia (high triglycerides) in a patient with a history of pancreatitis?
What is the appropriate management for a patient with hemodynamic instability, considering their medical history and potential underlying conditions such as cardiac or respiratory issues?
What are the management and treatment options for a patient with a reactive Roche (Electrochemiluminescence immunoassay) Elecsys (Electrochemiluminescence immunoassay system) Herpes Simplex Virus type 2 (HSV-2) Immunoglobulin G (IgG) assay result?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.